rs141207681: Longevity & Cellular Pathway Variant

What each genotype means

Genomic Context and Variant Characteristics

The single nucleotide polymorphism rs141207681 represents a specific sequence variation within the human genome cataloged by public databases such as dbSNP. In general longevity screening studies, variants are evaluated across coding, non-coding, and intergenic territories to identify loci enriched in individuals who reach extreme old age. When mapped across human reference sequences, rs141207681 is characterized by a low minor allele frequency across reference datasets like gnomAD, placing it into the category of rare variation rather than common population polymorphism. In genomic analyses evaluating centenarians and supercentenarians, researchers utilize high-throughput variant annotation frameworks to catalog non-synonymous, regulatory, and intergenic variations. This variant falls into an analytical category highlighted in cohorts surviving past the age of 100, where scientists systematically map rare divergence from standard population controls to understand how distinct genomic architectures influence longevity.

Research Findings in Longevity and Cellular Survival

Genome-wide profiling of extreme longevity has historically demonstrated that living beyond a century involves complex genetic architectures that may counter typical age-related disease trajectories. Modern sequencing studies investigating centenarians and supercentenarians, such as analyses utilizing Betterhumans Inc. genomic datasets and public variant annotation tools, have isolated specific loci showing functional divergence across survival pathways. In these longevity screens, rs141207681 was identified among variant sets examined for functional enrichment in biological processes such as cellular stress responses, mitochondrial maintenance, and signal transduction cascades. Extreme longevity cohorts often exhibit unique distributions of both protective loci and rare variants that influence cellular maintenance. However, because rs141207681 was characterized primarily through comparative sequencing datasets with modest sample sizes, its statistical evidence strength is currently considered moderate, requiring larger replication cohorts to confirm causality.

Population Frequency and Ancestry Patterns

A critical benchmark in assessing the functional relevance of any candidate variant is its distribution across broad human reference populations. According to large-scale sequencing resources such as the Genome Aggregation Database (gnomAD) and the 1000 Genomes Project, rs141207681 exhibits a minor allele frequency (MAF) of less than 0.01 (less than 1%). Because the variant is so infrequent across global populations, it rarely appears in standard commercial direct-to-consumer genotyping arrays, which predominantly target common variants. In comparative analyses of exceptionally long-lived individuals, the presence of rare alleles that deviate from broader population background frequencies offers clues into evolutionary selection and physiological resilience. Nonetheless, because frequency baselines can vary noticeably between ancestries, interpreting rs141207681 requires careful matching of ethnic backgrounds to prevent population stratification artifacts.

Clinical Utility and Consumer Interpretation

Finding or seeking rs141207681 in personal genetic data should be approached with realistic expectations regarding the science of human aging. Currently, rs141207681 does not possess a clinical classification in ClinVar, nor does it serve as an established medical biomarker for lifespan prediction. Carrying or not carrying a specific rare allele at this position cannot guarantee or prevent healthy aging, as human longevity is an intensely polygenic trait shaped by thousands of minor-effect genetic loci interacting with lifestyle, socioeconomic status, and environmental conditions. Individuals curious about their aging biology should recognize that lifestyle interventions—such as regular physical activity, balanced nutrition, cardiovascular health management, and routine preventative care—hold validated, substantial impacts on healthspan, whereas individual rare variants remain exploratory research topics.

Frequently asked questions

Sources & further reading

Related variants